Conference - Boston, MA, United States
Meet Thought Leaders in Cancer Immunotherapy at the Premier Annual IO Event As our understanding of tumor immunology has advanced, immuno-oncology has made unprecedented progress in improving the outcomes for cancer patients. Still, with the field in its infancy, the full curative potential of IO has yet to be realized. CHI’s 4th Annual Immuno-Oncology Summit has been designed to support a coordinated effort by industry players to bring commercial immunotherapies and immunotherapy combinations through clinical development and into the market. This weeklong, nine-meeting set will include topics ranging from early discovery through clinical development as well as emerging areas such as oncolytic virotherapy. Overall, this event will provide a focused look at how researchers are applying new science and technology in the development of the next generation of effective and safe immunotherapies.
Scientific leaders, C-level executives, professors, site directors and researchers from pharma, biotech, academia, and government working in the areas of immuno-oncology, immunotherapy, antibody and protein engineering, biomarker discovery, immunology, cell and gene therapy, and preclinical and clinical development
Organization: Cambridge Healthtech Institute
For more information, please visit: http://www.immuno-oncologysummit.com
Monday, August 29, 2016 to Friday, September 02, 2016
Marriott Long Wharf Hotel
Boston, Massachusetts, U.S.A.
Contact: chi@healthtech.com
